Immunology and Microbiology
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1
73%
Neutralizing Antibody
33%
Virus
30%
Neutralization
29%
Human Immunodeficiency Virus Type 1 Subtype C
27%
Human Immunodeficiency Virus Infection
24%
Epitope
24%
Blood Plasma
19%
Viral Load
14%
Cytokine
13%
Tenofovir
12%
Prevalence
9%
T Cell
9%
Antimicrobial Agent
9%
CD4 Lymphocyte Count
8%
Gp41
8%
Vaginitis
8%
CD4
8%
T-Helper Cell
8%
Lineages
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Omicron Coronavirus Variant
7%
Antibody Response
7%
Glycan
7%
Cladistics
6%
Cytotoxic T-Cell
6%
Seroconversion
6%
Inflammatory Cytokine
5%
Amino Acid
5%
Monoclonal Antibody
5%
Allele
5%
Cytotoxic T Cell
5%
CAPRISA 004
5%
Arm
5%
Medicine and Dentistry
Human Immunodeficiency Virus
80%
Infection
20%
Antiretroviral Therapy
18%
Human Immunodeficiency Virus Infection
16%
Antimicrobial Agent
14%
Tenofovir
12%
Randomized Controlled Trial
10%
Public Health
9%
Prevalence
9%
COVID-19
7%
Sexually Transmitted Infection
6%
Diseases
6%
Placebo
6%
Condom Use
5%
Sex Worker
5%
Primary Health Care
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
67%
Antimicrobial Agent
26%
Tenofovir
24%
Human Immunodeficiency Virus Infection
18%
Infection
18%
Placebo
10%
Prevalence
7%
Randomized Controlled Trial
6%
Clinical Trial
6%
Pharmacokinetics
5%
Monoclonal Antibody
5%
Su mensaje fue enviado correctamente.
Su mensaje no fue enviado debido a un error.